Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EDIT stock hub

Editas Medicine, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EDITis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

304.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

EDIT

In the news

Latest news · EDIT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-326.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-96.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EDIT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001650664
Company name	Editas Medicine, Inc.
Country	United States
Country code	US
Cusip	28106W103
Employees	87
Employees Change	-159%
Employees Change Percent	-64.63
Enterprise value	$198.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2016-02-03
Isin	US28106W1036
Last refreshed	2026-05-10
Market cap	$304.5M
Market cap category	Small-Cap
Price	$3.11
Price currency	USD
Rev Per Employee	444,747.13x
Sector	Healthcare
Sic	2836
Symbol	EDIT
Website	https://www.editasmedicine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-35.78%
EV Sales Forward	11.16x
EV/Sales	5.12x
FCF yield	-46.34%
P/B ratio	69.07x
P/S ratio	7.87x
PS Forward	17.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-230.09%
EBITDA Margin	-220.16%
Gross margin	-109.24%
Gross Profit	$-42.3M
Net Income	$-109M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Pretax Margin	-281.59%
Profit Margin	-281.59%
Profit Per Employee	$-1.3M
ROA	-26.95
Roa5y	-24.58
ROCE	-81.26
ROE	-326.1
Roe5y	-85.66
ROIC	-96.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-20.32%
Cagr1y	133.97%
Cagr3y	-31.71%
Cagr5y	-38.06%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	7.97x
Revenue Growth Q	-39.22x
Revenue Growth Years	1x
Revenue Growth3 Y	19.29x
Revenue Growth5 Y	-15.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.19
Assets	$149.3M
Cash	$123.6M
Current Assets	$128.1M
Current Liabilities	$39.8M
Debt	$17.3M
Debt Equity	$3.92
Equity	$4.4M
Interest Coverage	-17.71
Liabilities	$144.9M
Long Term Assets	$21.3M
Long Term Liabilities	$105.2M
Net Cash	$106.4M
Net Cash By Market Cap	$34.93
Net Cash Growth	-43.98%
Net Debt Equity	$-24.13
Tangible Book Value	$4.4M
Tangible Book Value Per Share	$0.05
WACC	16.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.22
Net Working Capital	$-28.7M
Quick ratio	3.17
Working Capital	$88.3M
Working Capital Turnover	$0.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.9%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-89.68%
1Y total return	133.84%
200-day SMA	2.65
3Y total return	-68.17%
50-day SMA	2.72
50-day SMA vs 200-day SMA	50over200
5Y total return	-90.88%
All Time High	99.95
All Time High Change	-96.89%
All Time High Date	2021-01-08
All Time Low	0.91
All Time Low Change	241.72%
All Time Low Date	2025-04-07
ATR	0.23
Beta	2.14
Beta1y	2.11
Beta2y	2.2
Ch YTD	51.71
High	3.23
High52	4.54
High52 Date	2025-10-08
High52ch	-31.45%
Low	3.03
Low52	1.29
Low52 Date	2025-05-08
Low52ch	141.09%
Ma50ch	14.51%
Premarket Change Percent	0.99
Premarket Price	$3.06
Premarket Volume	1,811
Price vs 200-day SMA	17.54%
RSI	54.82
RSI Monthly	44.76
RSI Weekly	58.78
Sharpe ratio	1.32x
Sortino ratio	2.31
Total Return	-11.9%
Tr YTD	51.71
Tr1m	13.5%
Tr1w	7.24%
Tr3m	70.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	3
Analyst Price Target Top	$5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.25
Earnings Revenue Estimate	6,474,304x
Earnings Revenue Estimate Growth	38.99x
Operating Income	$-89M
Operating margin	-230.1
Price target	$5.4
Price Target Change	$73.63
Price Target Change Top	$60.77

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97,636,421%
Float Percent	99.72%
Shares Insiders	0.28%
Shares Institutions	51.86%
Shares Out	97,906,282
Shares Qo Q	0.64%
Shares Yo Y	11.9%
Short Float	11.18%
Short Ratio	7.13
Short Shares	11.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-150.2M
Average Volume	1,440,053.15x
Bv Per Share	0.05
CAPEX	$-585,000
Ch10y	-89.68
Ch1m	13.5
Ch1w	7.24
Ch1y	133.8
Ch3m	70.88
Ch3y	-68.17
Ch5y	-90.88
Ch6m	25.91
Change	2.64%
Change From Open	2.64
Close	3.03
Days Gap	0
Depreciation Amortization	3,843,000
Dollar Volume	3,468,048.1
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$-89M
EBITDA	$-85.2M
EPS	$-1.18
F Score	3
FCF	$-141.1M
FCF EV Yield	-71.21x
FCF Per Share	$-1.44
Financing CF	41,907,000
Fiscal Year End	December
Founded	2,013
Investing CF	82,345,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-09
Ma150	2.59
Ma150ch	19.94%
Ma20	3.16
Ma20ch	-1.49%
Net CF	-16,251,000
Next Earnings Date	2026-08-11
Open	3.03
Optionable	Yes
Position In Range	40
Post Close	3.11
Postmarket Change Percent	-0.34
Postmarket Price	$3.1
Ppne	18,296,000
Pre Close	3.03
Price Date	2026-05-08
Ptbv Ratio	69.08
Relative Volume	0.77x
Revenue	38,693,000x
SBC By Revenue	23.58x
Share Based Comp	9,123,000
Tr6m	25.91%
Us State	Massachusetts
Volume	1,115,128
Z Score	-15.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EDIT pay a dividend?

Capital-return profile for this ticker.

Performance

EDIT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EDIT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+51.9%

Float: +99.7% of shares outstanding

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

EDIT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.8

Neutral momentum band

Price vs 200-day MA

+17.5%

50/200-day relationship not available

Beta (5Y)

2.14

More volatile than the market

Sharpe ratio

1.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EDIT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current EDIT stock rating?

Editas Medicine, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EDIT analysis?

The full report lives at /stocks/EDIT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for EDIT?

The latest report frames EDIT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the EDIT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.